Disclosed is a liquid medicament/supplement composition including a non-winterizedmarine source oil (e.g., oil derived from fish, krill, and/or squid) , a foodgrade orpharmaceutically acceptable form of vitamin D3 or a derivative thereof admixedin thenon-winterized marine source oil, a food grade or pharmaceutically acceptableform of vitamin A or aderivative thereof admixed in the non-winterized marine source oil, optionallya food grade orpharmaceutically acceptable form of CoQ10 or a derivative thereof admixed inthenon-winterized marine source oil, a food grade or pharmaceutically acceptableform of concentratedeicosapentaenoic acid and docosahexaenoic acid or ethyl ester, glyceride esteror salt of the acidand polyphenol rich vegetable oil admixed in the non-winterized marine sourceoil, andoptionally a food grade or pharmaceutically acceptable form of melatonin or aderivative thereofadmixed in the non-winterized marine source oil. The liquidmedicament/supplementcomposition preferably has an oxidation amount measured as totox of less than5, and the liquidmedicament/supplement composition preferably has an overall eicosapentaenoicacid todocosahexaenoic acid ratio (DHA:EPA) ranging from 2:1 to 1:2 at aconcentration ranging from15 to 35 wt% of total liquid weight calculated as weight % of thecorresponding free acid.
